Lyell Immunopharma, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Lyell Immunopharma, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Lyell Immunopharma, Inc. Assets for the quarter ending September 30, 2024 was $619M, a 22.1% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$619M	-$176M	-22.1%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$654M	-$181M	-21.7%	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$694M	-$186M	-21.2%	Mar 31, 2024	10-Q	2024-05-06
Q4 2023	$750M	-$188M	-20%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$795M	-$182M	-18.7%	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$835M	-$186M	-18.2%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$880M	-$192M	-17.9%	Mar 31, 2023	10-Q	2023-05-04
Q4 2022	$938M	-$190M	-16.8%	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$977M	-$221M	-18.4%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$1.02B	-$208M	-16.9%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$1.07B			Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$1.13B	+$219M	+24.1%	Dec 31, 2021	10-K	2023-02-28
Q3 2021	$1.2B			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$1.23B			Jun 30, 2021	10-Q	2021-08-12
Q4 2020	$908M			Dec 31, 2020	10-K	2022-03-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.